Loading…
← CockpitCompetitor Analysis › 601336.SS New China Life Insurance Co., Ltd. Class AOpen in the cockpit ↗

New China Life Insurance Co., Ltd. Class A601336.SSCompetitor analysis, valuation and peers

China · CNY·Financials›Multi-Line Insurance

Life insurer focused on individual and group life, health and annuity products, distributed through agents and bancassurance.

Momentum weak 37
Mkt cap
$21.7B
US dollars, full cap
Free float
33%
of shares outstanding
$/day
$100M
20-day average traded
P/B
1.27×
price to book
ROE
22.4%
delivered
Implied ROE
13.6%
what the price asks
Next earnings
146 days
1 Apr 2027
Close · CNYCN¥52.37
1D-1.1%
1W+4.2%
1M-6.7%
3M-16.7%
6M-18.7%
YTD-24.9%
1Y-23.9%
ATR %2.2%
52w lowhigh39.0% off high

What New China Life Insurance does

Life insurer focused on individual and group life, health and annuity products, distributed through agents and bancassurance.

Collects premiums on long-term life, health and savings-type policies and invests the money until benefits fall due, so investment income matters alongside insurance margins. Policies are sold through its own agents and bank branches. Central Huijin, a Chinese state investment arm, is the largest shareholder.

Products and services

  • Life insurance
  • Health insurance
  • Annuities

Customers

  • Retail policyholders

Where it sits in the supply chain

  • Financial services
  • Life insurance
  • Life, health, annuity products

What could go right

  • Life/health premium growth

What could go wrong

  • Investment-return volatility
  • Agent-channel productivity decline

Moat: narrow (scale, distribution). Established national agent and bancassurance distribution network among China's top life insurers.

Headquarters: Beijing, China · Founded: 1996

Named competitors

New China Life Insurance at a glance

Size New China Life Insurance (601336.SS) is a China Financials company (Multi-Line Insurance) with a market value of $21.7B, the 94th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥52.37 on 6 Nov 2026.

Performance Over six months the shares fell 18.7%, against +11.3% for the median peer and -16.4% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.

Growth Revenue grew 18.7% over the last twelve months (peer median +6.5%); the operating margin is 17.6% (peer median 9.4%).

Valuation It trades at 1.27× book value against a peer median of 1.68× (6th cheapest of 21).

Price implies The share price implies a return on equity of about 13.6%; New China Life Insurance delivers 22.4%, so the price asks less than the business earns today.

Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 112601336.SS 81
Six months, rebased to 100: New China Life Insurance against the median of its 20 peers (local-currency closes).

New China Life Insurance financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥158BCN¥134BCN¥96.5BCN¥78.1BCN¥109B
Revenue growth—+39%+23%-28%—
Net incomeCN¥25.7BCN¥36.3BCN¥26.2BCN¥8.71BCN¥21.5B
Free cash flowCN¥112BCN¥109BCN¥95.2BCN¥89.5BCN¥86.7B
Capital expenditureCN¥1.27BCN¥1.48BCN¥1.10BCN¥2.09BCN¥1.79B
Total debtCN¥198BCN¥214BCN¥203BCN¥128BCN¥54.5B

Quarterly statements and history in the cockpit →

New China Life Insurance competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%-10%0%+10%+20%0%+10%LGENUNIHBANASRNLWRBCINFPZUAV2378BNTSUNPUKGJFMAPACGLCNAAGNUNMGL8630601336.SS6-month return →1-month return →
Up and to the right = strong over both horizons. New China Life Insurance is the large dot.

Fundamentals: return on equity against price-to-book

10%20%20×40×60×LGENUNIHBANASRNLWRBCINFPZUAV2378BNTSUNPUKGJFMAPCNAAGNUNMGL8630601336.SSReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. New China Life Insurance is the large dot.

Capital: ROE delivered against the ROE the price implies

0%20%40%60%0%20%40%60%LGENUNIHBANASRNLCINFPZUAV2378BNTSUNGJFCNA601336.SSROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. New China Life Insurance is the large dot.

New China Life Insurance competitors and peer comparison

Head to head with its named competitors (601336.SS vs 601628.SS vs 601318.SS vs 601601.SS)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
New China Life Insurance 601336.SS$21.7B-19%+19%22%1.27×13.6%
China Life Insurance 601628.SS$135B-3%+16%12%1.54×13.1%
Ping An Insurance (Group) Company of China 601318.SS$136B-8%+12%14%0.96×7.4%
China Pacific Insurance (Group) 601601.SS$42.6B-14%+4%14%0.93×8.2%

How New China Life Insurance compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

New China Life Insurance against its 20 peers (data as of 6 Nov 2026)
Measure601336.SSPeer medianRank in peer set
1-month return-6.7%+4.0%2nd lowest of 21
6-month return-18.7%+11.3%3rd lowest of 21
Return on equity22.4%15.7%3rd highest of 21
Price / book1.27×1.68×6th cheapest of 21
Trailing P/E6.3×11.7×cheapest of 20
ROE the price implies13.6%10.9%6th most demanding of 21
ROE delivered22.4%14.6%3rd highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
New China Life Insurance 601336.SSChina$21.7B-19%+19%22%1.27×13.6%22.4%
Legal & General LGEN.LUnited Kingdom$21.9B+24%+137%26%7.73×70.7%26.2%
Unipol Assicurazioni UNI.MIItaly$23.8B+13%+7%17%1.62×14.9%16.9%
Helvetia Baloise HBAN.SWSwitzerland$27.0B+5%+54%4%1.80×4.8%4.0%
ASR Nederland ASRNL.ASNetherlands$17.3B+14%+6%13%1.74×8.3%13.1%
W. R. Berkley WRBUnited States$27.9B+16%+1%19%2.91×12.8%19.2%
Cincinnati Financial CINFUnited States$28.5B+15%+10%17%1.76×10.6%16.9%
Powszechny Zaklad Ubezpieczen Spolka Akcyjna PZU.WAPoland$16.1B+15%+1%20%1.83×19.5%19.5%
Aviva AV..LUnited Kingdom$29.5B+18%+86%7%2.46×23.8%6.8%
Prudential 2378.HKHong Kong$30.8B-24%+30%19%1.54×11.3%19.3%
Brookfield Wealth Solutions BNT.TOCanada$14.9B-8%-18%1%0.70×9.4%0.7%
Suncorp SUN.AXAustralia$14.9B+21%-3%10%2.08×11.7%9.8%
Prudential plc Sponsored ADR PUKUnited States$31.7B-21%+39%19%1.56×11.4%19.2%
Gjensidige Forsikring GJF.OLNorway$14.7B+9%+7%30%5.73×19.1%29.9%
Mapfre MAP.MCSpain$14.1B-2%+5%12%1.26×8.4%12.4%
Arch Capital ACGLUnited States$36.6B+14%-5%19%1.58×8.3%18.7%
CNA Financial CNAUnited States$12.8B+9%+2%10%1.25×7.2%9.6%
Aegon AGN.ASNetherlands$12.7B+4%+16%10%1.25×8.2%10.5%
Unum UNMUnited States$12.2B-5%-5%3%1.52×8.1%2.6%
Globe Life GLUnited States$12.1B+4%+6%21%2.08×11.7%n/a
Sompo 8630.TJapan$39.6B+17%+41%15%1.14×6.2%14.6%

Questions

Who are New China Life Insurance's main competitors?
Named competitors: China Life Insurance (601628.SS), Ping An Insurance (601318.SS), China Pacific Insurance (601601.SS). The cockpit's measured peer set (industry) also includes Legal & General (LGEN.L), Unipol Assicurazioni (UNI.MI), Helvetia Baloise (HBAN.SW), ASR Nederland (ASRNL.AS), W. R. Berkley (WRB), Cincinnati Financial (CINF).
Is New China Life Insurance expensive compared with its peers?
On price / book it trades at 1.27× against a peer median of 1.68×, 6th cheapest of 21 in its peer set. The share price implies a return on equity of about 13.6%; New China Life Insurance delivers 22.4%, so the price asks less than the business earns today.
How has New China Life Insurance stock performed?
Over six months to 6 Nov 2026 the shares returned -18.7% against +11.3% for the median peer; over one year -23.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.